{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Stérigmatocystine : Questions médicales les plus fréquentes",
"headline": "Stérigmatocystine : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Stérigmatocystine : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-03-02",
"dateModified": "2025-02-25",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Stérigmatocystine"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Mycotoxines",
"url": "https://questionsmedicales.fr/mesh/D009183",
"about": {
"@type": "MedicalCondition",
"name": "Mycotoxines",
"code": {
"@type": "MedicalCode",
"code": "D009183",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D23.946.587"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Stérigmatocystine",
"alternateName": "Sterigmatocystin",
"code": {
"@type": "MedicalCode",
"code": "D013241",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Veronica Zingales",
"url": "https://questionsmedicales.fr/author/Veronica%20Zingales",
"affiliation": {
"@type": "Organization",
"name": "Laboratory of Food Chemistry and Toxicology, Faculty of Pharmacy, University of Valencia, Av. Vicent Andrés Estellés s/n, 46100, Valencia, Spain. Electronic address: vezin@uv.es."
}
},
{
"@type": "Person",
"name": "Mónica Fernández-Franzón",
"url": "https://questionsmedicales.fr/author/M%C3%B3nica%20Fern%C3%A1ndez-Franz%C3%B3n",
"affiliation": {
"@type": "Organization",
"name": "Laboratory of Food Chemistry and Toxicology, Faculty of Pharmacy, University of Valencia, Av. Vicent Andrés Estellés s/n, 46100, Valencia, Spain."
}
},
{
"@type": "Person",
"name": "Maria-José Ruiz",
"url": "https://questionsmedicales.fr/author/Maria-Jos%C3%A9%20Ruiz",
"affiliation": {
"@type": "Organization",
"name": "Laboratory of Food Chemistry and Toxicology, Faculty of Pharmacy, University of Valencia, Av. Vicent Andrés Estellés s/n, 46100, Valencia, Spain."
}
},
{
"@type": "Person",
"name": "Ildikó Bata-Vidács",
"url": "https://questionsmedicales.fr/author/Ildik%C3%B3%20Bata-Vid%C3%A1cs",
"affiliation": {
"@type": "Organization",
"name": "Department of Environmental and Applied Microbiology, Agro-Environmental Research Institute, National Agricultural Research and Innovation Centre, 1022 Budapest, Hungary."
}
},
{
"@type": "Person",
"name": "József Kukolya",
"url": "https://questionsmedicales.fr/author/J%C3%B3zsef%20Kukolya",
"affiliation": {
"@type": "Organization",
"name": "Department of Environmental and Applied Microbiology, Agro-Environmental Research Institute, National Agricultural Research and Innovation Centre, 1022 Budapest, Hungary."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Identification of attention deficit hyperactivity disorder with deep learning model.",
"datePublished": "2023-05-16",
"url": "https://questionsmedicales.fr/article/37191853",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s13246-023-01275-y"
}
},
{
"@type": "ScholarlyArticle",
"name": "Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD).",
"datePublished": "2023-03-27",
"url": "https://questionsmedicales.fr/article/36971690",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/14651858.CD009885.pub3"
}
},
{
"@type": "ScholarlyArticle",
"name": "Altered somatosensory processing in adult attention deficit hyperactivity disorder.",
"datePublished": "2024-08-13",
"url": "https://questionsmedicales.fr/article/39138461",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12888-024-06002-9"
}
},
{
"@type": "ScholarlyArticle",
"name": "Parental perspectives on attention-deficit/hyperactivity disorder treatments for children.",
"datePublished": "2022-06-13",
"url": "https://questionsmedicales.fr/article/35695509",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1177/13591045221108836"
}
},
{
"@type": "ScholarlyArticle",
"name": "Potential Inflammatory Biomarker in Patients with Attention Deficit Hyperactivity Disorder.",
"datePublished": "2022-10-27",
"url": "https://questionsmedicales.fr/article/36361835",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/ijms232113054"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Facteurs biologiques",
"item": "https://questionsmedicales.fr/mesh/D001685"
},
{
"@type": "ListItem",
"position": 3,
"name": "Toxines biologiques",
"item": "https://questionsmedicales.fr/mesh/D014118"
},
{
"@type": "ListItem",
"position": 4,
"name": "Mycotoxines",
"item": "https://questionsmedicales.fr/mesh/D009183"
},
{
"@type": "ListItem",
"position": 5,
"name": "Stérigmatocystine",
"item": "https://questionsmedicales.fr/mesh/D013241"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Stérigmatocystine - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Stérigmatocystine",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-10",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Stérigmatocystine",
"description": "Comment diagnostiquer une intoxication à la stérigmatocystine ?\nQuels tests sont utilisés pour détecter la stérigmatocystine ?\nQuels symptômes indiquent une exposition à la stérigmatocystine ?\nY a-t-il des marqueurs biologiques spécifiques ?\nComment évaluer l'exposition environnementale ?",
"url": "https://questionsmedicales.fr/mesh/D013241?mesh_terms=Attention+Deficit+Disorder+with+Hyperactivity&page=3#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Stérigmatocystine",
"description": "Quels sont les symptômes d'une intoxication aiguë ?\nLa stérigmatocystine cause-t-elle des effets à long terme ?\nQuels signes indiquent une atteinte hépatique ?\nY a-t-il des symptômes neurologiques associés ?\nComment les symptômes varient-ils selon l'exposition ?",
"url": "https://questionsmedicales.fr/mesh/D013241?mesh_terms=Attention+Deficit+Disorder+with+Hyperactivity&page=3#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Stérigmatocystine",
"description": "Comment prévenir l'exposition à la stérigmatocystine ?\nQuelles mesures de sécurité en milieu de travail ?\nLes tests de qualité des aliments sont-ils utiles ?\nComment gérer les cultures à risque ?\nY a-t-il des recommandations pour les consommateurs ?",
"url": "https://questionsmedicales.fr/mesh/D013241?mesh_terms=Attention+Deficit+Disorder+with+Hyperactivity&page=3#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Stérigmatocystine",
"description": "Quel est le traitement principal pour l'intoxication ?\nDes antidotes existent-ils pour la stérigmatocystine ?\nComment gérer les symptômes gastro-intestinaux ?\nQuand faut-il hospitaliser un patient ?\nY a-t-il des traitements préventifs ?",
"url": "https://questionsmedicales.fr/mesh/D013241?mesh_terms=Attention+Deficit+Disorder+with+Hyperactivity&page=3#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Stérigmatocystine",
"description": "Quelles sont les complications possibles d'une intoxication ?\nComment la stérigmatocystine affecte-t-elle le foie ?\nY a-t-il un risque de cancer associé ?\nQuels sont les effets sur le système immunitaire ?\nDes effets sur la reproduction sont-ils possibles ?",
"url": "https://questionsmedicales.fr/mesh/D013241?mesh_terms=Attention+Deficit+Disorder+with+Hyperactivity&page=3#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Stérigmatocystine",
"description": "Qui est le plus à risque d'intoxication ?\nLes enfants sont-ils plus vulnérables ?\nQuel rôle joue l'alimentation dans le risque ?\nLes personnes immunodéprimées sont-elles à risque ?\nComment l'environnement influence-t-il le risque ?",
"url": "https://questionsmedicales.fr/mesh/D013241?mesh_terms=Attention+Deficit+Disorder+with+Hyperactivity&page=3#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une intoxication à la stérigmatocystine ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur l'historique d'exposition et des tests biologiques pour détecter la toxine."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour détecter la stérigmatocystine ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des analyses de sang et d'urine peuvent être effectuées pour détecter la présence de la toxine."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent une exposition à la stérigmatocystine ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des nausées, vomissements, et des troubles hépatiques."
}
},
{
"@type": "Question",
"name": "Y a-t-il des marqueurs biologiques spécifiques ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il n'existe pas de marqueurs spécifiques, mais des tests hépatiques peuvent montrer des anomalies."
}
},
{
"@type": "Question",
"name": "Comment évaluer l'exposition environnementale ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des échantillons d'air et de sol peuvent être analysés pour détecter la présence de champignons producteurs."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes d'une intoxication aiguë ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes aigus incluent des douleurs abdominales, des vomissements et des diarrhées."
}
},
{
"@type": "Question",
"name": "La stérigmatocystine cause-t-elle des effets à long terme ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une exposition prolongée peut entraîner des effets cancérigènes et des dommages hépatiques."
}
},
{
"@type": "Question",
"name": "Quels signes indiquent une atteinte hépatique ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les signes incluent une jaunisse, des douleurs dans l'hypocondre droit et des anomalies des tests hépatiques."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes neurologiques associés ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes neurologiques comme des maux de tête et des vertiges peuvent survenir."
}
},
{
"@type": "Question",
"name": "Comment les symptômes varient-ils selon l'exposition ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes varient selon la dose et la durée d'exposition, allant de légers à graves."
}
},
{
"@type": "Question",
"name": "Comment prévenir l'exposition à la stérigmatocystine ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Évitez de consommer des aliments moisis et assurez-vous d'une bonne conservation des aliments."
}
},
{
"@type": "Question",
"name": "Quelles mesures de sécurité en milieu de travail ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des mesures de sécurité incluent l'utilisation d'équipements de protection et une bonne ventilation."
}
},
{
"@type": "Question",
"name": "Les tests de qualité des aliments sont-ils utiles ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des tests réguliers peuvent aider à détecter la présence de mycotoxines dans les aliments."
}
},
{
"@type": "Question",
"name": "Comment gérer les cultures à risque ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il est essentiel de surveiller et de contrôler l'humidité et la température des cultures."
}
},
{
"@type": "Question",
"name": "Y a-t-il des recommandations pour les consommateurs ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les consommateurs doivent inspecter les aliments et éviter ceux présentant des signes de moisissure."
}
},
{
"@type": "Question",
"name": "Quel est le traitement principal pour l'intoxication ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement consiste principalement en des soins de soutien et l'élimination de la toxine."
}
},
{
"@type": "Question",
"name": "Des antidotes existent-ils pour la stérigmatocystine ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il n'existe pas d'antidote spécifique pour la stérigmatocystine."
}
},
{
"@type": "Question",
"name": "Comment gérer les symptômes gastro-intestinaux ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des antiémétiques et des réhydratations peuvent être administrés pour soulager les symptômes."
}
},
{
"@type": "Question",
"name": "Quand faut-il hospitaliser un patient ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'hospitalisation est nécessaire en cas de symptômes graves ou de défaillance hépatique."
}
},
{
"@type": "Question",
"name": "Y a-t-il des traitements préventifs ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "La prévention repose sur l'évitement de l'exposition aux champignons producteurs de toxines."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications possibles d'une intoxication ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent des lésions hépatiques, des troubles neurologiques et un risque accru de cancer."
}
},
{
"@type": "Question",
"name": "Comment la stérigmatocystine affecte-t-elle le foie ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle peut provoquer une hépatite toxique, entraînant des dommages cellulaires et une insuffisance hépatique."
}
},
{
"@type": "Question",
"name": "Y a-t-il un risque de cancer associé ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exposition prolongée à la stérigmatocystine est associée à un risque accru de cancer du foie."
}
},
{
"@type": "Question",
"name": "Quels sont les effets sur le système immunitaire ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "La stérigmatocystine peut affaiblir le système immunitaire, augmentant la susceptibilité aux infections."
}
},
{
"@type": "Question",
"name": "Des effets sur la reproduction sont-ils possibles ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des études suggèrent que la stérigmatocystine peut avoir des effets néfastes sur la reproduction."
}
},
{
"@type": "Question",
"name": "Qui est le plus à risque d'intoxication ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les personnes travaillant dans l'agriculture ou la transformation des aliments sont plus à risque."
}
},
{
"@type": "Question",
"name": "Les enfants sont-ils plus vulnérables ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les enfants sont plus vulnérables aux effets toxiques en raison de leur poids corporel plus faible."
}
},
{
"@type": "Question",
"name": "Quel rôle joue l'alimentation dans le risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation riche en aliments moisis augmente le risque d'exposition à la stérigmatocystine."
}
},
{
"@type": "Question",
"name": "Les personnes immunodéprimées sont-elles à risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes immunodéprimées sont plus susceptibles de subir des effets graves de la toxine."
}
},
{
"@type": "Question",
"name": "Comment l'environnement influence-t-il le risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des conditions humides et chaudes favorisent la croissance des champignons producteurs de toxines."
}
}
]
}
]
}
This article explores the detection of Attention Deficit Hyperactivity Disorder, a neurobehavioral disorder, from electroencephalography signals. Due to the unstable behavior of electroencephalography...
Attention deficit hyperactivity disorder (ADHD) is one of the most commonly diagnosed and treated psychiatric disorders in childhood. Typically, children and adolescents with ADHD find it difficult to...
To assess the beneficial and harmful effects of methylphenidate for children and adolescents with ADHD....
We searched CENTRAL, MEDLINE, Embase, three other databases and two trials registers up to March 2022. In addition, we checked reference lists and requested published and unpublished data from manufac...
We included all randomised clinical trials (RCTs) comparing methylphenidate versus placebo or no intervention in children and adolescents aged 18 years and younger with a diagnosis of ADHD. The search...
Two review authors independently conducted data extraction and risk of bias assessment for each trial. Six review authors including two review authors from the original publication participated in the...
We included 212 trials (16,302 participants randomised); 55 parallel-group trials (8104 participants randomised), and 156 cross-over trials (8033 participants randomised) as well as one trial with a p...
methylphenidate versus placebo or no intervention may improve teacher-rated ADHD symptoms (standardised mean difference (SMD) -0.74, 95% confidence interval (CI) -0.88 to -0.61; I² = 38%; 21 trials; 1...
methylphenidate may cause more adverse events considered non-serious versus placebo or no intervention (RR 1.23, 95% CI 1.11 to 1.37; I² = 72%; 35 trials 5342 participants; very low-certainty evidence...
The majority of our conclusions from the 2015 version of this review still apply. Our updated meta-analyses suggest that methylphenidate versus placebo or no-intervention may improve teacher-rated ADH...
Tactile sensitivity and sensory overload in ADHD are well-documented in clinical-, self-, and parent- reports, but empirical evidence is scarce and ambiguous and focuses primarily on children. Here, w...
Somatosensory evoked potential (SEP) amplitudes were measured in 27 adults with ADHD and 24 controls during four conditions (rest, stroking of the own arm, stroking of the arm by a researcher, and str...
Participants with ADHD self-reported greater tactile sensitivity and ADHD symptom severity than controls and received higher scores on the Qb-test. These values correlated with one another. ADHD parti...
We find that ADHD symptomatology and touch sensitivity are directly linked, using both self-reports and experimental measures. We also find evidence of tactile sensory overload in ADHD, and an indicat...
This study investigated parental perspectives and experiences on the evaluation and treatment process associated with attention-deficit/hyperactivity disorder (ADHD). Five hundred sixty-eight parents ...
Attention deficit hyperactivity disorder (ADHD) is a prevalent neurodevelopmental disorder that can diminish the quality of life of both children and adults in academic, occupational, and social conte...
The aim is to assess the sensory processing difficulties in children and adolescents with ADHD....
In all, 38 ADHD children of the age group 6-14 years and 34 age- and gender-matched typically developing controls were included in the study. Sensory processing was assessed on Child Sensory Profile-2...
A significantly higher sensory processing difficulties were seen in children with ADHD than typically developing controls. There were positive correlations between the scores of Child sensory profile ...
Sensory problems were common in children with ADHD and add to the functional impairments....
To investigate the association between the risk of attention-deficit/hyperactivity disorder (ADHD) and preterm birth and determine how postnatal complications in children born preterm is associated wi...
This population-based cohort study used data from the Hong Kong electronic medical records. We followed 359 614 children (48% female; 6-17 years old, mean 11 years 7 months, SD 3 years 2 months) born ...
The risk of ADHD was 4.0% in children born at term and 5.1% in children born preterm. The odds ratio for ADHD was 2.08 (95% confidence interval [CI] 1.64-2.64) for children born extremely preterm, 1.6...
Children born preterm in all subcategories, from extremely preterm to late preterm, have increased risk of ADHD. Early respiratory infection partially mediates the risk of ADHD in children born preter...
Measurement-informed care is a cornerstone of evidence-based practice and shared decision-making. A structured diagnostic interview specific to ADHD provides a globally agreed-on standard of evaluatio...
Despite advances in identifying rare and common genetic variants conferring risk for ADHD, the lack of a transcriptomic understanding of cortico-striatal brain circuitry has stymied a molecular mechan...
Attention-deficit/hyperactivity disorder (ADHD) is one of the most common neurodevelopmental disorders of childhood, and is often characterized by altered executive functioning. Executive function has...